Lower Plasma Elabela Levels in Hypertensive Patients With Heart Failure Predict the Occurrence of Major Adverse Cardiac Events: A Preliminary Study

Lignende værker

• The Elabela-APJ axis: a promising therapeutic target for heart failure
  af: Ma, Zheng, et al.
  Udgivet: (2020)
• Plasma levels of Elabela are associated with coronary angiographic severity in patients with acute coronary syndrome
  af: DU, Sheng-Li, et al.
  Udgivet: (2020)
• Major Adverse Limb Events and Major Adverse Cardiac Events after Contemporary Lower Extremity Bypass and Infrainguinal Endovascular Intervention in Patients with Claudication
  af: Fashandi, Anna Z, et al.
  Udgivet: (2018)
• Plasma miR-142 predicts major adverse cardiovascular events as an intermediate biomarker of dual antiplatelet therapy
  af: Tang, Qian-jie, et al.
  Udgivet: (2018)
• Endothelial Cell‐Related Proteins in Plasma Predict Major Adverse Cardiovascular Events and Worsening Heart Failure in Patients With Hypertrophic Cardiomyopathy
  af: Shogo Tamura, et al.
  Udgivet: (2025-10-01)